ICCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
IceCure Medical Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 17, 2026
$1.08+0.02 (+1.89%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 0.1
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 12, 2026 | Before market open | – | – | – |
| Q4 FY2025 Ended Dec 31, 2025 | Jan 12, 2026 | Before market open | – | – | – |
| Q2 FY2025 Ended Jun 30, 2025 | Jul 3, 2025 | Before market open | $525.00K | – | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 27, 2025 | Before market open | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Jan 10, 2024 | Before market open | – | – | – |
| Q2 FY2023 Ended Jun 30, 2023 | Aug 14, 2023 | Before market open | – | – | – |
| Q4 FY2022 Ended Dec 31, 2022 | Feb 9, 2023 | Before market open | – | – | – |
| Q2 FY2022 Ended Jun 30, 2022 | Aug 15, 2022 | After market close | – | – | – |
| Q4 FY2021 Ended Dec 31, 2021 | Jan 31, 2022 | Before market open | – | – | – |
Press releases
Announcements IceCure Medical filed with the SEC
UNAUDITED INTERIM CONDENSED CONSOLIDATED BALANCE SHEET
EX-99.1 to Form 6-K
AMENDED AND RESTATED ARTICLES OF ASSOCIATION OF THE COMPANY
EX-99.1 to Form 6-K